Role of P glycoprotein in absorption of novel antimalarial drugs

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 10, 2006, Pages 3504-3506

  Crowe, Andrew ^a   Ilett, Kenneth F ^b   Karunajeewa, Harin A ^b   Batty, Kevin T ^a   Davis, Timothy M E ^b  

^a CURTIN UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; DIHYDROARTEMISININ; GLYCOPROTEIN P; NAPHTHOQUINONE; PIPERAQUINE; PYRONARIDINE; VALSPODAR;

APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; DRUG ABSORPTION; DRUG TRANSPORT; HUMAN; HUMAN CELL; PARTITION COEFFICIENT; PRIORITY JOURNAL;

ANTIMALARIALS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; HUMANS; INTESTINAL ABSORPTION; NAPHTHYRIDINES; P-GLYCOPROTEIN;

EID: 33749533053     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00708-06     Document Type: Article

References (15)

1. Ayrton, A., and P. Morgan. 2001. Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica 31:469-497.
2. Babalola, C. P., G. K. Scriba, A. Sowunmi, and O. A. Alawode. 2003. Liquid chromatographic determination of pyronaridine in human plasma and oral dosage forms. J. Chromatogr. B 795:265-272.
3. Crowe, A., and M. Lemaire. 1998. In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin. Pharm. Res. 15:1666-1672.
4. Crowe, A., and Y. K. Teoh. 2006. Limited P-glycoprotein mediated efflux for anti-epileptic drugs. J. Drug Target. 14:291-300.
5. Crowe, A., and P. Wong. 2004. pH dependent uptake of loperamide across the gastrointestinal tract: an in vitro study. Drug Dev. Ind. Pharm. 30:449-459.
6. Davis, T. M. E., T.-Y. Hung, I.-K. Sim, H. A. Karunajeewa, and K. F. Ilett. 2005. Piperaquine: a resurgent antimalarial drug. Drugs 65:75-87.
7. Ilett, K. F., and K. T. Batty. 2005. Artemisinin and its derivatives, p. 981-1002. In V. L. Yu, G. Edwards, P. S. McKinnon, C. Peloquin, and G. D. Morse (ed.), Antimicrobial therapy and vaccines-volume II: antimicrobial agents, 2nd ed. ESun Technologies, Pittsburgh, Pa.
8. Pereira, E., E. Teodori, S. Dei, F. Gualtieri, and A. Garnier-Suillerot. 1995. Reversal of multidrug resistance by verapamil analogues. Biochem. Pharmacol. 50:451-457.
9. Pham, Y. T., A. Regina, R. Farinotti, P. Couraud, I. W. Wainer, F. Roux, and F. Gimenez. 2000. Interactions of racemic mefloquine and its enantiomers with P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT. Biochim. Biophys. Acta 1524:212-219.
10. Qi, J., S. Wang, G. Liu, H. Peng, J. Wang, Z. Zhu, and C. Yang. 2004. Pyronaridine, a novel modulator of P-glycoprotein-mediated multidrug resistance in tumor cells in vitro and in vivo. Biochem. Biophys. Res. Commun. 319:1124-1131.
11. Qi, J., C. Z. Yang, C. Y. Wang, S. B. Wang, M. Yang, and J. H. Wang. 2002. Function and mechanism of pyronaridine: a new inhibitor of P-glycoprotein-mediated multidrug resistance. Acta Pharmacol. Sin. 23:544-550.
12. Sim, I.-K., T. M. E. Davis, and K. F. Ilett. 2005. Effects of a high-fat meal on the relative oral bioavailability of piperaquine. Antimicrob. Agents Chemother. 49:2407-2411.
13. Wang, J. Y., W. C. Cao, C. Q. Shan, M. Zhang, G. F. Li, D. B. Ding, Y. L. Shi, and B. A. Wu. 2004. Naphthoquine phosphate and its combination with artemisinine. Acta Trop. 89:375-381.
14. Wu, C. Y., and L. Z. Benet. 2005. Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm. Res. 22:11-23.
15. Zhang, L., J. M. Strong, W. Qiu, L. J. Lesko, and S.-M. Huang. 2006. Scientific perspectives on drug transporters and their role in drug interactions. Mol. Pharm. 3:62-69.